(1)(a) The department shall contract with a private entity, that meets all of the conditions of paragraph (b), to establish and maintain, at no cost to the state, a statewide venous thromboembolism registry to ensure that the performance measures required to be submitted under subsection (2) are maintained and available for use to improve or modify the venous thromboembolism care system, ensure compliance with nationally recognized guidelines, and monitor venous thromboembolism patient outcomes.
(b)The private entity must: 1. Be a not-for-profit corporation qualified as tax-exempt under s. 501(c)(3) of the Internal Revenue Code. 2. Have existed for at least 15 consecutive years with a mission of advancing the prevention, early diagnosis, and successful treatment of blood clots. 3. Have ex
Free access — add to your briefcase to read the full text and ask questions with AI
(1)(a) The department shall contract with a private entity, that meets all of the conditions of paragraph (b), to establish and maintain, at no cost to the state, a statewide venous thromboembolism registry to ensure that the performance measures required to be submitted under subsection (2) are maintained and available for use to improve or modify the venous thromboembolism care system, ensure compliance with nationally recognized guidelines, and monitor venous thromboembolism patient outcomes. (b) The private entity must: 1. Be a not-for-profit corporation qualified as tax-exempt under s. 501(c)(3) of the Internal Revenue Code. 2. Have existed for at least 15 consecutive years with a mission of advancing the prevention, early diagnosis, and successful treatment of blood clots. 3. Have experience operating a medical registry with at least 25,000 participants. 4. Have experience in providing continuing education on venous thromboembolism to medical professionals. 5. Have sponsored a public health education campaign on venous thromboembolism. 6. Be affiliated with a medical and scientific advisory board.
(2) Beginning July 1, 2026, each hospital with an emergency department shall regularly report to the statewide venous thromboembolism registry information containing nationally recognized venous thromboembolism measures and data on the incidence and prevalence of venous thromboembolisms. Such data must include the following information: (a) The number of venous thromboembolisms identified and diagnosed. (b) The age of the patient. (c) The zip code of the patient. (d) The sex of the patient. (e) The race and ethnicity of the patient. (f) Whether the patient is a resident of a licensed nursing home or assisted living facility. (g) Whether the venous thromboembolism was fatal. (h) How the diagnosis was made, such as by using imaging modalities. (i) The treatment that was recommended for the venous thromboembolism.
(3) The department shall require the contracted private entity to use a nationally recognized platform to collect data from each hospital with an emergency department on the performance measures required under subsection (2). The contracted private entity shall provide regular reports to the department on the data collected.
(4) By June 1, 2026, the agency must submit to the Governor, the President of the Senate, and the Speaker of the House of Representatives a detailed report on the incidence of venous thromboembolism using inpatient and outpatient data for services provided between July 1, 2024, and June 30, 2025. The report shall provide analyses of all of the following: (a) Age category, initial primary diagnosis and procedure, and secondary diagnoses, readmission rates for inpatients, admission rates for venous thromboembolism for which the patient had an ambulatory surgery procedure, and emergency department visits for venous thromboembolism linked to any previous admission. (b) Whether the venous thromboembolism was present upon admission. (c) The incidence of venous thromboembolism procedures reported on the agency’s Florida Health Finder website. (d) The principal payor, the sex of the patient, and the patient’s discharge status.
(5) The contracted private entity operating the registry may only use or publish information from the registry for the purposes of advancing medical research or medical education in the interest of reducing morbidity or mortality.